Medical Developments International Limited
Medical Developments International Limited (MVP.AX) Financial Performance & Income Statement Overview
Review Medical Developments International Limited (MVP.AX) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Medical Developments International Limited (MVP.AX) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Medical Developments International Limited MVP.AX financial performance.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $18.07M | $15.08M | $18.41M | $13.93M |
| Cost of Revenue | $15.12M | $20.53M | $20.15M | $14.71M |
| Gross Profit | $2.95M | -$5.45M | -$1.73M | -$782000.00 |
| Gross Profit Ratio | $0.16 | -$0.36 | -$0.09 | -$0.06 |
| R&D Expenses | $0.00 | $0.00 | $236000.00 | $0.00 |
| SG&A Expenses | $6.82M | $7.55M | $10.39M | $7.37M |
| Operating Expenses | $6.82M | $7.55M | $10.39M | $7.37M |
| Total Costs & Expenses | $21.93M | $28.08M | $30.54M | $22.07M |
| Interest Income | $143000.00 | $259000.00 | $459000.00 | $198000.00 |
| Interest Expense | $42000.00 | $44000.00 | $46000.00 | $49000.00 |
| Depreciation & Amortization | $1.87M | $1.53M | $1.53M | $1.58M |
| EBITDA | -$18.23M | -$11.21M | -$9.44M | $5.16M |
| EBITDA Ratio | -$1.009 | -$0.76 | -$0.58 | -$0.47 |
| Operating Income | -$3.87M | -$13.00M | -$12.12M | -$8.15M |
| Operating Income Ratio | -$0.21 | -$0.86 | -$0.66 | -$0.59 |
| Other Income/Expenses (Net) | -$16.27M | $215000.00 | $1.11M | $11.67M |
| Income Before Tax | -$20.14M | -$12.78M | -$11.01M | $3.52M |
| Income Before Tax Ratio | -$1.11 | -$0.85 | -$0.60 | $0.25 |
| Income Tax Expense | $9.90M | -$1.84M | -$2.75M | $864000.00 |
| Net Income | -$30.05M | -$10.95M | -$8.27M | $2.66M |
| Net Income Ratio | -$1.66 | -$0.73 | -$0.45 | $0.19 |
| EPS | -$0.34 | -$0.12 | -$0.09 | $0.03 |
| Diluted EPS | -$0.34 | -$0.12 | -$0.09 | $0.03 |
| Weighted Avg Shares Outstanding | $88.60M | $88.60M | $88.60M | $84.47M |
| Weighted Avg Shares Outstanding (Diluted) | $88.60M | $88.60M | $88.60M | $90.99M |
Over the last four quarters, Medical Developments International Limited achieved steady financial progress, growing revenue from $13.93M in Q2 2023 to $18.07M in Q4 2024. Gross profit stayed firm with margins at 16% in Q4 2024 versus -6% in Q2 2023. Operating income totaled -$3.87M in Q4 2024, maintaining a -21% margin over recent quarters. Despite shifts in R&D and SG&A costs, EBITDA stayed strong at -$18.23M. Net income dropped to -$30.05M, with EPS at -$0.34. Disciplined expense strategies and efficient operations ensured sustained profitability and long-term financial stability.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan